Trasylol (aprotinin injection) is used for prophylactic use to reduce blood loss and the need for blood transfusion in patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery who are at an increased risk for blood loss and blood transfusion. On November 5, 2007 The U.S. Food and Drug Administration announced that Bayer Pharmaceuticals (the makers of Trasylol) agreed to the FDA- requested suspension of Trasylol. Trasylol was recalled because heart bypass, heart valve replacement and other cardiac surgery patients who received Trasylol were more likely to die. The deaths were due to:
• kidney failure
• heart failure
• heart attacks
• and strokes the patients suffered following the surgery.
The attorneys of Fears and Nachawati are helping people in cases of Trasylol lawsuits. If you or someone you know needs assistance and require financial compensation due to Trasylol complications or death contact the lawyers at Fears and Nachawati. Fears and Nachawati are located in Dallas, Fort Worth, Austin, Houston, and San Antonio:
Fears and Nachawati Attorneys & Counselors
4925 Greenville Avenue
Suite 715
Dallas, Texas 75206
Phone: (214) 890.0711
mn@fnlawfirm.com
*Principal Office
*Se Habla Espanol